Drug Type Small molecule drug |
Synonyms Acolbifene/prasterone, DHEA/Acolbifene, Dehydroepiandrosterone/Acolbifene + [2] |
Target |
Mechanism AR agonists(Androgen Receptor agonists), ERs agonists(Estrogen receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H28O2 |
InChIKeyFMGSKLZLMKYGDP-USOAJAOKSA-N |
CAS Registry53-43-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hot Flashes | Phase 3 | CA | 01 Oct 2011 | |
Vascular Diseases | Phase 3 | CA | 01 Oct 2011 | |
Breast Cancer | Phase 3 | CA | - | |
Decreased libido | Phase 2 | CA | - | |
Hypogonadism | Phase 2 | CA | - |